Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 09:41:48 GMT 2023
by
admin
on
Sat Dec 16 09:41:48 GMT 2023
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
M6030H73N9
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
||
|
NCI_THESAURUS |
C129822
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB15017
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
PRIMARY | |||
|
BC-80
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL2109638
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
PRIMARY | |||
|
1353485-38-7
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
PRIMARY | |||
|
C97510
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
PRIMARY | |||
|
10165
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
PRIMARY | |||
|
Enoblituzumab
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL3545373
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
PRIMARY | |||
|
M6030H73N9
Created by
admin on Sat Dec 16 09:41:48 GMT 2023 , Edited by admin on Sat Dec 16 09:41:48 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_234 | 2_234 |
| 1_231 | 2_231 |
| 2_225 | 4_214 |
| 1_225 | 3_214 |
| 4_134 | 4_194 |
| 4_23 | 4_88 |
| 3_134 | 3_194 |
| 3_23 | 3_88 |
| 2_372 | 2_430 |
| 2_266 | 2_326 |
| 2_149 | 2_205 |
| 2_22 | 2_96 |
| 1_372 | 1_430 |
| 1_266 | 1_326 |
| 1_149 | 1_205 |
| 1_22 | 1_96 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_302 |
| N | 2_302 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|